Promising news from a European oncolog... - Lung Cancer Support

Lung Cancer Support

4,066 members2,214 posts

Promising news from a European oncology meeting

MFH_Advocate profile image
2 Replies

Some news on lung cancer treatments from the European Society for Medical Oncology (or ESMO):

- A new immunotherapy (atezolizumab or Tecentriq) improved survival vs chemo as second-line therapy for patients with NSCLC. This drug could be FDA-approved by October 19.

- Pembrolizumab (Keytruda) improved survival vs chemo as first-line therapy in patients with NSCLC if they had high levels of the biomarker PD-L1. Pembrolizumab is already approved as second-line therapy (for NSCLC), but could be FDA-approved as first-line therapy by December 24.

Written by
MFH_Advocate profile image
MFH_Advocate
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Katie31278 profile image
Katie31278

I have been fighting lung cancer and just had my 5 year anniversary. I have had surgery, chemo, cyber knife radiation more chemo and now on Opdivo. I was diagnosed with stage 4 but it has not moved from my lungs. Prayer from so many people and my I don't give up attitude have helped me on my way. Stat positive and hopefully in the neat future they will find a cure

deloresthompson profile image
deloresthompson in reply toKatie31278

How are u stage 4 if only in lung.I too have stage4 nsclc had l/3 out 2 1/2 yes ago mi b e came back 1 yr yo lymph nodes abd brain had radiation on chest and lymph nodes. 3 gamma knivesfor brain met .been on optivo for 6 months no growth or movement in,last 3 chest scans praying for all cancer fighters

Not what you're looking for?

You may also like...

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

On May 18th, 2020, the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) for the...
Miranda_GO2 profile image
Partner

Study presented at the European Society for Medical Oncology (ESMO) Congress may mean a new way to treat patients with stage 3 lung cancer

This past week, results of some key studies were presented at a major meeting in Spain. One study,...
MFH_Advocate profile image

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

On December 18th, 2020, the Food and Drug Administration (FDA) approved Tagrisso (osimertinib) for...
Miranda_GO2 profile image
Partner

An immunotherapy now approved for first-line treatment

Late yesterday, the FDA approved Keytruda (an immunotherapy) as a first-line treatment for patients...

Update on my dad, stage IV NSCLC, and Help needed

Hi everyone! It has been a whirlwind few weeks so I'm back to update on my dad and also hoping to...
Lisam81 profile image

Moderation team

See all
AmyKamp profile image
AmyKampAdministrator
SarahMcHale profile image
SarahMcHaleAdministrator
Maureen-GO2 profile image
Maureen-GO2Administrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.